Breast Cancer Trial

BOSTON, May 5, 2026 Sensei Biotherapeutics, Inc. has announced the first patient dosing in its Phase 1b/2 clinical trial...

VERO BEACH, Fla. | January 5, 2026 — Processa Pharmaceuticals, Inc. has completed enrollment and dosing of the 20th...